Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labianca

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract CancerR Labianca, G Giaccon, S Barni, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, E Aitini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Journal of Clinical Gastroenterology|March 1, 1994
Stages I and II non-Hodgkin's lymphoma of the gastrointestinal tract. Retrospective analysis of 79 patients and review of the literatureL Tedeschi, A Romanelli, G Dallavalle, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 4, 2018
Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of ColoproctologyV P Bastiaenen, I Hovdenak Jakobsen, R Labianca, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
Population-based sentinel lymph node biopsy in early invasive breast cancerP Fenaroli, M Merson, L Giuliano, et al.
British Journal of Cancer|February 23, 1999
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, G Comella, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract CancerR Labianca, G Giaccon, S Barni, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, E Aitini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
Journal of Clinical Gastroenterology|March 1, 1994
Stages I and II non-Hodgkin's lymphoma of the gastrointestinal tract. Retrospective analysis of 79 patients and review of the literatureL Tedeschi, A Romanelli, G Dallavalle, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 4, 2018
Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of ColoproctologyV P Bastiaenen, I Hovdenak Jakobsen, R Labianca, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
Population-based sentinel lymph node biopsy in early invasive breast cancerP Fenaroli, M Merson, L Giuliano, et al.
British Journal of Cancer|February 23, 1999
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, L Frontini, G Comella, et al.
Pageof 17